| Closed |
SWOG-8508 |
Combination Chemotherapy of Intermediate and High- Grade Non-Hodgkin's Lymphoma with MACOP-B |
11/6/1985 |
6/1/1986 |
|
|
Published
|
| Closed |
SWOG-8503 |
Combination Chemotherapy of Intermediate and High- Grade Non-Hodgkin's Lymphoma with ProMACE-CytaBOM |
4/26/1985 |
11/15/1985 |
|
|
Published
|
| Closed |
SWOG-8112 |
Combination Chemotherapy of Unfavorable Histology Non-Hodgkin's Lymphoma with CHOP and CVB |
1/5/1982 |
12/23/1982 |
|
|
Published
|
| Closed |
SWOG-8245 |
Combination Chemotherapy of Unfavorable Histology Non-Hodgkin's Lymphoma with CHOP and CVB (Alternating) |
12/23/1982 |
3/16/1984 |
|
|
Published
|
| Closed |
SWOG-8385 |
Combination Chemotherapy with Cis-Platinum, Vinblastine and Methyl Glyoxal Bis (Guanylhydrazone)(MGBG) in Non-Small Cell Lung Cancer |
2/24/1984 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-8311 |
Combination Chemotherapy with Cis-Platinum, Vinblastineand Methyglyoxal Bis (Guanylhydrazone)(MGBG) in Epidermoid Carcinoma of the Esophagus |
7/26/1983 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-7922 |
Combination Chemotherapy with Cyclophosphamide, Adriamycin, and Cis-Platinum vs. m-AMSA in Patients with Advanced Transitional Cell Cancer of the Urinary Bladder with Good Renal Function |
8/8/1979 |
9/10/1982 |
|
|
Published
|
| Closed |
SWOG-8264 |
Combination Chemotherapy with m-AMSA, Cis-Platinum and MGBG for Refractory Lymphoma |
8/11/1962 |
3/16/1984 |
|
|
Published
|
| Closed |
SWOG-8325 |
Combination Chemotherapy With O,P'-DDD and Cis-Platinum in Metastatic Adrenal Carcinoma |
1/19/1984 |
7/1/1989 |
|
|
Published
|
| Closed |
SWOG-7521 |
Combination Chemotherapy with or without Immuno- therapy in High-Risk Melanoma Patients: An Adjuvant Study |
11/24/1975 |
7/29/1981 |
|
|
Published
|
| Closed |
SWOG-8308 |
Combination Cis-Platinum and Dichloromethotrexate |
10/18/1983 |
3/14/1986 |
|
|
Published
|
| Closed |
SWOG-7628 |
Combined CT/RT/IT for Oat Cell Cancer of the Lung |
10/28/1976 |
3/14/1979 |
|
|
Published
|
| Closed |
SWOG-8568 |
Combined Modality Therapy for Advanced Stage III Breast Cancer or Localized Stage IV (T3B, Any N, T3aN2-3, or Any T4) |
3/4/1986 |
11/15/1990 |
85% |
|
Published
|
| Closed |
SWOG-7827 |
Combined Modality Therapy For Breast Carcinoma Phase III |
7/16/1979 |
8/1/1989 |
100% |
|
Published
|
| Closed |
SWOG-8024 |
Combined Modality Therapy for Disseminated Soft Tissue Sarcomas |
11/25/1980 |
6/16/1986 |
|
|
Published
|
| Closed |
SWOG-7828 |
Combined Modality Therapy for Extensive Small-Cell Carcinoma of the Lung |
11/17/1978 |
12/3/1980 |
|
|
Published
|
| Closed |
SWOG-8229/30 |
Combined Modality Therapy for Multiple Myeloma, VMCP-VBAP for Remission Induction Therapy: VMCP vs. Sequential Half-Body Radiotherapy + Vincristine-Prednisone for Maintenance or Consolidation… |
10/15/1982 |
11/15/1988 |
|
|
Published
|
| Closed |
SWOG-8068 |
Combined Modality Treatment for Limited Adenocarcinoma and Large-Cell Carcinoma of the Lung: Radiation Therapy plus 5-FU, Mitomycin-C and Vincristine |
9/24/1980 |
3/30/1983 |
|
|
Published
|
| Closed |
SWOG-7808 |
Combined Modality Treatment for Stages III and IV Hodgkin's Disease. |
6/1/1978 |
12/1/1987 |
|
|
Published
|
| Closed |
SWOG-8122 |
Combined Modality Treatment of Extensive Small Cell Lung Cancer |
3/30/1982 |
3/22/1985 |
|
|
Published
|
